(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 15.09% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.47%.
Radnet's revenue in 2026 is $2,144,442,000.On average, 11 Wall Street analysts forecast RDNT's revenue for 2026 to be $199,652,325,204, with the lowest RDNT revenue forecast at $189,272,606,052, and the highest RDNT revenue forecast at $207,830,285,748. On average, 10 Wall Street analysts forecast RDNT's revenue for 2027 to be $222,298,985,172, with the lowest RDNT revenue forecast at $203,348,134,296, and the highest RDNT revenue forecast at $239,598,517,092.
In 2028, RDNT is forecast to generate $248,326,917,288 in revenue, with the lowest revenue forecast at $233,700,949,392 and the highest revenue forecast at $267,277,768,164.